EXPO 2027 Belgrade: 200 Days to Go as Business and Tourism Preparations Accelerate Share Post Post navigation Previous PostEpson’s Point-of-Sale Solutions Bring Streamlined Order Pickup to Multi-Vendor Food Hall in FloridaNext Post Henlius reports positive results from ASTRIDE U.S. bridging study for serplulimab in combination with chemotherapy for first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC)